Scisparc Palmitoylethanolamide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scisparc palmitoylethanolamide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scisparc Palmitoylethanolamide Today - Breaking & Trending Today

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , Tel Aviv , Scisparc Palmitoylethanolamide , Adi Zuloff Shani , Frankfurt Stock Exchange , Scisparc Ltd , Medicine Inc , Clearmind Medicine Inc , Canadian Securities Exchange , Exchange Commission , Trademark Office , Clearmind Medicine , United States Patent , Chief Executive Officer , Tourette Syndrome , Private Securities Litigation Reform Act ,

SciSparc and Clearmind Collaboration Continues to Increase its Patent Portfolio in the Field of Movement Abnormalities in the U.S.

SciSparc and Clearmind Collaboration Continues to Increase its Patent Portfolio in the Field of Movement Abnormalities in the U.S.
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , Scisparc Palmitoylethanolamide , Oz Adler , Scisparc Ltd , Exchange Commission , Trademark Office , Company Or Scisparc , Clearmind Medicine Inc , Tourette Syndrome , Clearmind Medicine , United States Patent , Chief Executive Officer , Looking Statements , Private Securities Litigation Reform Act , Annual Report ,

EXCLUSIVE: Clearmind Medicine Files US Patent Application For Dyskinesia Treatment, Strengthening Its IP Portfolio - Clearmind Medicine (NASDAQ:CMND)

Clearmind Medicine Inc (NASDAQ: CMND) has announced the filing of a provisional patent application for the treatment of Dyskinesia with the United States Patent and Trademark Office (USPTO) as part of its overarching strategy to strengthen its IP portfolio further. ....

United States , Scisparc Palmitoylethanolamide , Trademark Office , Scisparc Ltd , Clearmind Medicine , United States Patent ,